GREEN CROSS WellBeing Corporation (234690) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.030x

Based on the latest financial reports, GREEN CROSS WellBeing Corporation (234690) has a cash flow conversion efficiency ratio of 0.030x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.38 Billion ≈ $2.29 Million USD) by net assets (₩111.99 Billion ≈ $75.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

GREEN CROSS WellBeing Corporation - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how GREEN CROSS WellBeing Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of GREEN CROSS WellBeing Corporation for a breakdown of total debt and financial obligations.

GREEN CROSS WellBeing Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GREEN CROSS WellBeing Corporation ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
AptaBio Therapeutics Inc
KQ:293780
-0.061x
Whitestone Group
BR:ROCK
N/A
Burning Rock Biotech Ltd
NASDAQ:BNR
0.031x
Bougainville Copper Limited
F:BOU1
-0.025x
SHIMAO SERV.HLDGS HD-01
F:5GO
N/A
AGV Products Corp
TW:1217
0.017x
Desa Deri Sanayi ve Ticaret AS
IS:DESA
-0.039x
Vitro S.A.B. de C.V
MX:VITROA
0.205x

Annual Cash Flow Conversion Efficiency for GREEN CROSS WellBeing Corporation (2016–2024)

The table below shows the annual cash flow conversion efficiency of GREEN CROSS WellBeing Corporation from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see GREEN CROSS WellBeing Corporation (234690) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩104.95 Billion
≈ $71.13 Million
₩13.71 Billion
≈ $9.29 Million
0.131x +1372.80%
2023-12-31 ₩100.39 Billion
≈ $68.03 Million
₩-1.03 Billion
≈ $-698.19K
-0.010x -154.11%
2022-12-31 ₩96.16 Billion
≈ $65.17 Million
₩1.82 Billion
≈ $1.24 Million
0.019x -80.72%
2021-12-31 ₩88.30 Billion
≈ $59.84 Million
₩8.68 Billion
≈ $5.89 Million
0.098x +231.95%
2020-12-31 ₩83.08 Billion
≈ $56.30 Million
₩-6.19 Billion
≈ $-4.20 Million
-0.075x -214.49%
2019-12-31 ₩83.17 Billion
≈ $56.36 Million
₩5.41 Billion
≈ $3.67 Million
0.065x -65.52%
2018-12-31 ₩28.84 Billion
≈ $19.55 Million
₩5.45 Billion
≈ $3.69 Million
0.189x +14.22%
2017-12-31 ₩24.84 Billion
≈ $16.83 Million
₩4.11 Billion
≈ $2.78 Million
0.165x +321.59%
2016-12-31 ₩20.94 Billion
≈ $14.19 Million
₩-1.56 Billion
≈ $-1.06 Million
-0.075x --

About GREEN CROSS WellBeing Corporation

KQ:234690 Korea Biotechnology
Market Cap
$154.29 Million
₩227.67 Billion KRW
Market Cap Rank
#17533 Global
#823 in Korea
Share Price
₩12830.00
Change (1 day)
-4.75%
52-Week Range
₩8530.00 - ₩15100.00
All Time High
₩16468.03
About

GREEN CROSS WellBeing Corporation provides personalized nutrition injections in South Korea. The company offers health supplements and food; prescription drugs; and aesthetics, as well as nutritional injections, including vitamins and antioxidants. GREEN CROSS WellBeing Corporation was founded in 2004 and is headquartered in Seoul, South Korea.